Company Intelligence Profile
Difgen Pharmaceuticals Private Limited
Difgen Pharmaceuticals Private Limited is the Hyderabad (Telangana)-based Indian subsidiary/affiliate of DifGen Pharmaceuticals LLC (Miramar, Florida, USA), engaged in scientific research & development / pharmaceutical R&D activities.
Last updated 20 August 2026
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
Company Identity
Confirmed| Registered name | Difgen Pharmaceuticals Private Limited |
|---|---|
| CIN | U24230TG2022PTC162383 |
| PAN | Not available in the public sources reviewed. |
| Status | Active |
| Listing | Not listed — unlisted private limited company |
| Incorporated | 06 May 2022 |
| ROC | RoC Hyderabad |
| Sector (NIC) | Sector: "Research and Development Services" / "Professional, scientific and technical activities" — NIC: Scientific research and development |
| Registered address | 5-35/189A, Survey No. 390, Prashanthi Nagar, 100 Feet Road, IE Kukatpally, Rangareddy, Kukatpally, Balanagar, Hyderabad, Telangana - 500072 |
| Authorized capital | ₹1,00,00,000 (₹1 Crore) |
| Paid-up capital | ₹1,00,00,000 (₹1 Crore) per Tofler/TheCompanyCheck latest pull; note an earlier search snippet cited ₹1,00,000 paid-up — treat paid-up capital as partial/conflicting between ₹1 Crore and ₹1,00,000 across sources; ₹1 Crore is the figure both dedicated fetches returned and is treated as the more current figure |
Business Overview
Partial / conflicting- Difgen Pharmaceuticals Private Limited is the Hyderabad (Telangana)-based Indian subsidiary/affiliate of DifGen Pharmaceuticals LLC (Miramar, Florida, USA), engaged in scientific research & development / pharmaceutical R&D activities
- The India entity is recognized as a DPIIT "Recognised Startup." The US parent group develops and manufactures generic and specialty pharmaceutical products (injectables, ophthalmics, topicals, transdermal patches/dissolvable films, soft gels, solid orals) and recently acquired an FDA-registered finished-dosage manufacturing facility in Florida, expanding sterile/non-sterile inhalation, ophthalmic, otic and unit-dose manufacturing
- Approx. 92 employees reported for the India entity per EPFO data
- Confidence: partial (group-level info from press/LinkedIn, India-entity-specific activity detail is thin)
Directors
Partial / conflictingConfirmed via Tofler (9 listed) and TheCompanyCheck (11 listed, overlapping) — union list below; DINs available only from Tofler:
| Name | DIN | Role | Appointed |
|---|---|---|---|
| Yatin Kirtanlal Desai | 00030719 | - | - |
| Punit Chunilal Thakrar | 00351619 | - | - |
| Amol Ashok Walke | 00664315 | - | - |
| Zubin Keki Gandhi | 00664632 | - | - |
| Vijay Kumar Vasireddy | 03262782 | - | - |
| Srinivasan Vedantham | 09534573 | - | - |
| Santhanakrishnan Srinivasan | 09789679 | - | - |
| Ramandeep Singh Jaj | 09789813 | - | - |
| Krishna Chandrasekaran | 10243796 | - | - |
| Valiveti Brahmaji | - | - | - |
GST Registrations
Confirmed| GSTIN | State | PAN | Status |
|---|---|---|---|
| 36AAJCD2630H1ZT | Telangana | Not obtained — PAN not disclosed on Tofler, TheCompanyCheck, or Masters India GST page (all say "not disclosed/not provided") | Active |
Primary GSTIN: 36AAJCD2630H1ZT (Telangana, state code 36) — Legal/Trade Name: DIFGEN PHARMACEUTICALS PRIVATE LIMITED — Registration Date: 13 June 2022 — Status: Active — Taxpayer type: Regular — Nature of business: Supplier of Services, Export & Import — Principal place of business: Door No. 5-35/189-A, 100 Ft Road, Prashanthi Nagar, IE Kukatpally, Hyderabad, Medchal Malkajgiri, Telangana 500072 (source: Masters India / search aggregation). PAN embedded in GSTIN: AAJCD2630H. Home state: Telangana. Number of GSTIN registrations: only 1 confirmed (Telangana); page referenced an "Other GST Numbers" section but no additional registrations were listed. Status: confirmed for the single Telangana GSTIN; "not obtained" for any additional state registrations.
Financials
Partial / conflictingFY2025 (year ended 31 March 2025), per TheCompanyCheck (detailed) and Tofler (range/ratios) — standalone, entity level unspecified (likely standalone, India entity):
| Revenue | ₹76.63 Crore / Tofler range ₹75-100 Crore — YoY growth 84.15%/84% |
|---|---|
| Gross Margin | 10.82%; Operating Margin: 25.39%; Net Profit Margin: 23.39% |
| ROCE | 35.3%; Debt-to-Equity: 48.87 |
| EBITDA, PAT (absolute ₹), Net Worth | locked/premium on both Tofler and TheCompanyCheck — not obtained |
| Borrowings | growth of 0.39%; Total secured borrowings/open charges ₹50.95 Lakh with HDFC Bank per TheCompanyCheck (two charges: ₹26.87L registered 28 May 2024, ₹24.08L registered 25 Jul 2022) vs Tofler's earlier snapshot showing a single ₹0.2 Crore (₹20L) charge dated 25 July 2022 — treat charge amounts as partial/evolving (additional charge registered later; both sources agree on lender = HDFC Bank and on the 25-Jul-2022 charge date) |
| Assets change | -2.6% |
Overall: revenue figure confirmed (2 sources agree); EBITDA/PAT/net worth not obtained (paywalled on both platforms).
Charges / Loans
Partial / conflicting- Lender = HDFC Bank Limited
- TheCompanyCheck (more recent pull) reports two open charges totaling ₹50.95 Lakh: ₹26.87 Lakh registered 28 May 2024, and ₹24.08 Lakh registered 25 Jul 2022
- Tofler's snapshot shows one loan/charge of ₹0.2 Crore (₹20 Lakh) dated 25 July 2022 — likely an earlier/stale snapshot before the 2024 charge was added
- Treat total open charge quantum (₹50.95L, 2 charges) as the more current/confirmed figure
Competitors
Partial / conflictingFrequently Asked Questions
What does Difgen Pharmaceuticals Private Limited do?
What is the CIN of Difgen Pharmaceuticals Private Limited?
Where is Difgen Pharmaceuticals Private Limited registered?
When was Difgen Pharmaceuticals Private Limited incorporated?
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.